NEW YORK (GenomeWeb News) – BioDiscovery and N-of-One today announced a marketing agreement to provide genomic analysis interpretation solutions.

The companies will jointly market and sell N-of-One's interpretation solutions and content with BioDiscovery's genomic analysis software. The deal, they said, will allow clinicians to use genomic data more easily and efficiently to identify targeted therapies that are most appropriate for each individual patient and to better understand the molecular profile of the patient's tumor.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.